Pulmonary arterioles and capillary bed

The pulmonary arterioles and capillary bed represent the distal portion of the pulmonary circulatory system where gas exchange occurs between the blood and alveolar air (StatPearls, 2023). Arterioles are the primary resistance vessels in the lungs, and their tone is regulated by various paracrine factors and oxygen tension to maintain optimal ventilation-perfusion matching (PubMed, PMID: 28633906). In diseases such as pulmonary arterial hypertension (PAH), these vessels undergo significant structural remodeling, including medial hypertrophy and plexiform lesion formation, leading to increased pulmonary vascular resistance (NIH, 2022). This remodeling eventually leads to right-sided heart failure and significant morbidity if left untreated. Therapeutic strategies targeting this region focus on inducing vasodilation and inhibiting remodeling through pathways involving nitric oxide, endothelin-1, and prostacyclin (Journal of the American College of Cardiology, 2019). While not a single molecular target, this anatomical site is the functional focus for drugs like phosphodiesterase-5 inhibitors, endothelin receptor antagonists, and prostacyclin analogues (PubChem). Monitoring efficacy in this region often involves hemodynamic measurements such as mean pulmonary artery pressure and pulmonary vascular resistance. Safety concerns for drugs acting here include systemic hypotension and potential ventilation-perfusion mismatching.

Other names

Pulmonary microvasculaturePulmonary vascular bedPulmonary small vesselsPulmonary vasculature

Drugs acting on this region typically induce vasodilation and inhibit vascular remodeling by modulating the nitric oxide-cyclic GMP, endothelin, and prostacyclin signaling pathways within the vascular smooth muscle and endothelial cells (StatPearls, 2023).